Description
When various treatments have failed in the fight against metastatic non-small cell lung cancer, brigatinib is often the last resort. Brigatinib is only prescribed if your cancer has a specific genetic marker (an abnormal “ALK” gene). Your doctor will check for the presence of this gene. Despite its listed uses, brigatinib may have additional applications. Each film-coated tablet of Briganix contains 90mg of the active ingredient brigatinib INN. After years of investigation, Beacon Pharmaceuticals Limited has found the cure for lung cancer caused by brigatinib. This medication will help alleviate your discomfort.
Indications
Cancer of the lungs that has spread from other organs: People over the age of 18 whose lymphomas tested positive for Anaplastic lymphoma kinase (ALK) and who took crizotinib: You should start with 90 mg once a day for seven days. The dosage can be increased to 180 mg daily if this proves effective. Keep going until the condition worsens or the treatment’s adverse effects become intolerable.
One Unique Subset of Patients: When starting treatment with a potent CYP3A4 inhibitor, patients typically start with a reduced dose and gradually increase it to full strength.
Side Effects
Symptoms include sickness, loose stools, fatigue, head pain, and coughing.
- Gastrointestinal:
- Cardiovascular:
- The central nervous system (CNS):
- Air sacs and air sacs:
- Musculoskeletal:
- Precautions
Overdose
If a patient has taken an excessive amount of medication, it is strongly advised that they be monitored closely for any signs of bad reactions. Patients who encounter adverse reactions are entitled to the appropriate level of medical attention.
Storage
Brigatinib tablets should be stored in their original, labelled container at a temperature ranging from 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). Keep them out of the direct heat and away from any moisture. Ensure that youngsters and animals can’t get their hands on them.
Reviews
There are no reviews yet.